allergy

The French firm said that the funds will go toward international development and the marketing of the company's autoimmunity, allergy, and theranostic products. 

The companies will provide allergy diagnosis and testing services to clinicians, hospitals, and private laboratories in Southeast Asia.

The Early Gut

The gut microbiome appears to have a role in infants' later risk of developing allergies and asthma, a new study says.

The Food Allergy Science Initiative seeks to supply the basic scientific research needed to spur future development of diagnostics and therapeutics.

An autosomal dominant form of vibratory urticaria has been linked to a missense mutation in the ADGRE2 gene that appears to affect mast cell function and inflammation.

With the help of a newly generated gene regulatory network for T-cell differentiation, researchers identified transcription factors with ties to disease symptoms.

Researchers traced peanut allergy risk back to genetic and epigenetic factors in and around immune genes.

Using a genome-wide association study approach, investigators at the Children's Hospital of Philadelphia and elsewhere have uncovered four new risk loci for an inflammatory food allergy condition called eosinophilic esophagitis.

NEW YORK (GenomeWeb News) - In Lancet Respiratory Medicine, an international team led by investigators at the Duke University Medical Center described findings from a prospective study looking at asthma-related information that can be

NEW YORK (GenomeWeb News) – 23andMe today said it has received $573,000 in funding from the National Institutes of Health to support three projects using the Mountain View, Calif.-based company's web-based research platform.

Pages

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.